• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

T3a期肾细胞癌复发的预测因素：一个反复出现的难题。

Predictors of Recurrence for T3a RCC: A Recurring Conundrum.

作者信息

Leopold Zev, Srivastava Arnav, Singer Eric A

机构信息

Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Robert Wood Johnson Medical School, New Brunswick, NJ 08902, USA.

出版信息

Diagnostics (Basel). 2020 Nov 21;10(11):983. doi: 10.3390/diagnostics10110983.

DOI:10.3390/diagnostics10110983
PMID:33233477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7700179/
Abstract

Although the gold standard treatment for localized renal cell carcinoma (RCC) is radical nephrectomy (RN) or partial nephrectomy (PN), recurrence rates remain high at 7%, 26%, and 39% for T1, T2, and T3 staged disease, respectively [...].

摘要

尽管局限性肾细胞癌（RCC）的金标准治疗方法是根治性肾切除术（RN）或部分肾切除术（PN），但T1、T2和T3期疾病的复发率分别仍高达7%、26%和39% [...]。

相似文献

1
Predictors of Recurrence for T3a RCC: A Recurring Conundrum.T3a期肾细胞癌复发的预测因素：一个反复出现的难题。
Diagnostics (Basel). 2020 Nov 21;10(11):983. doi: 10.3390/diagnostics10110983.
2
Outcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: emphasis on partial nephrectomy.从小肾肿瘤升级为 T3a 期的肾细胞癌的病理分期结果：重点是部分肾切除术。
BMC Cancer. 2018 Apr 16;18(1):427. doi: 10.1186/s12885-018-4338-1.
3
Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a.部分肾切除术与根治性肾切除术相比，与临床 T1 期肾细胞癌病理升级为 T3a 的患者复发风险更高。
J Urol. 2017 Aug;198(2):289-296. doi: 10.1016/j.juro.2017.03.012. Epub 2017 Mar 6.
4
Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer.T3a 期肾细胞癌行部分肾切除术的肿瘤学结果。
Clin Genitourin Cancer. 2018 Jun;16(3):e613-e617. doi: 10.1016/j.clgc.2017.10.016. Epub 2017 Nov 7.
5
Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.部分肾切除术与根治性肾切除术相比，在老年 Ib-II 期肾肿块患者中并不具有总体生存优势：国家癌症数据库分析。
Cancer. 2018 Oct 1;124(19):3839-3848. doi: 10.1002/cncr.31582. Epub 2018 Sep 12.
6
Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.机器人辅助部分肾切除术治疗后临床 T1 到病理 T3a 肿瘤升级的结果和预测因素：多机构分析。
J Urol. 2013 Nov;190(5):1907-11. doi: 10.1016/j.juro.2013.06.014. Epub 2013 Jun 11.
7
Incidence of T3a up-staging and survival after partial nephrectomy: Size-stratified rates and implications for prognosis.肾部分切除术后T3a分期上调的发生率及生存情况：按大小分层的发生率及其对预后的影响。
Urol Oncol. 2018 Jan;36(1):12.e7-12.e13. doi: 10.1016/j.urolonc.2017.09.005. Epub 2017 Sep 29.
8
Hilar location is an independent prognostic factor for recurrence in T1 renal cell carcinoma after nephrectomy.肾门部位置是肾切除术后T1期肾细胞癌复发的独立预后因素。
Ann Surg Oncol. 2015 Jan;22(1):344-50. doi: 10.1245/s10434-014-4153-0. Epub 2014 Oct 17.
9
Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.部分肾切除术与根治性肾切除术治疗 T1b 和 T2 期临床肾肿瘤的比较：系统评价和荟萃分析。
Eur Urol. 2017 Apr;71(4):606-617. doi: 10.1016/j.eururo.2016.08.060. Epub 2016 Sep 7.
10
Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.cT1-2/N0/M0期透明细胞肾细胞癌行微创部分肾切除术与微创根治性肾切除术的肿瘤学结局：一项倾向评分匹配分析
World J Urol. 2017 May;35(5):789-794. doi: 10.1007/s00345-016-1923-2. Epub 2016 Aug 30.

引用本文的文献

1
Predictors of disease recurrence in high-risk non-metastatic renal cell carcinoma patients post-surgical resection A single-center, retrospective study.高危非转移性肾细胞癌患者术后疾病复发的预测因素：一项单中心回顾性研究
Can Urol Assoc J. 2024 Mar;18(3):E53-E58. doi: 10.5489/cuaj.8449.

本文引用的文献

1
To Be or "Node" to Be: Nodal Disease and the Role of Lymphadenectomy in the Treatment of Renal Cell Carcinoma.存在还是“结节”存在：淋巴结疾病及淋巴结切除术在肾细胞癌治疗中的作用
Med Res Arch. 2020 May;8(5). doi: 10.18103/mra.v8i5.2091. Epub 2020 May 25.
2
Impact of pathologic lymph node-positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancer.病理淋巴结阳性的肾细胞癌对无转移患者生存的影响：支持扩大 IV 期肾癌定义的证据。
Cancer. 2020 Jul 1;126(13):2991-3001. doi: 10.1002/cncr.32912. Epub 2020 Apr 24.
3
Clinical Significance of Tumor Size, Pathological Invasion Sites Including Urinary Collecting System and Clinically Detected Renal Vein Thrombus as Predictors for Recurrence in pT3a Localized Renal Cell Carcinoma.肿瘤大小、包括泌尿系统在内的病理侵袭部位以及临床检测到的肾静脉血栓作为pT3a期局限性肾细胞癌复发预测指标的临床意义
Diagnostics (Basel). 2020 Mar 12;10(3):154. doi: 10.3390/diagnostics10030154.
4
Strengthening the foundation of kidney cancer treatment and research: revising the AJCC staging system.加强肾癌治疗与研究基础：修订美国癌症联合委员会（AJCC）分期系统。
Ann Transl Med. 2019 Mar;7(Suppl 1):S33. doi: 10.21037/atm.2019.02.19.
5
The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?晚期肾细胞癌围手术期治疗的未来：我们如何才能取得成功？
Future Oncol. 2019 May;15(15):1683-1695. doi: 10.2217/fon-2018-0951. Epub 2019 Apr 10.
6
Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy.肿瘤大小对根治性肾切除术治疗的病理T3aN0M0肾细胞癌肿瘤学结局的影响。
PLoS One. 2017 Mar 13;12(3):e0173953. doi: 10.1371/journal.pone.0173953. eCollection 2017.
7
The role of neoadjuvant therapy in the management of locally advanced renal cell carcinoma.新辅助治疗在局部晚期肾细胞癌管理中的作用。
Ther Adv Urol. 2016 Apr;8(2):130-41. doi: 10.1177/1756287215612962. Epub 2015 Nov 20.
8
Invasion of the urinary collecting system is an independent prognostic factor in pT3 renal cell carcinoma.肾盂侵犯是pT3期肾细胞癌的一个独立预后因素。
Urol Oncol. 2016 Jul;34(7):293.e11-6. doi: 10.1016/j.urolonc.2016.02.019. Epub 2016 Mar 24.
9
Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?在 CORONA 项目的一项综合多中心研究中评估肾细胞癌患者 pT1-pT3a 局限性肿瘤中肾周脂肪侵犯和肿瘤大小的预后意义。我们能否改善 pT3a 期肿瘤患者的预后判别？
Eur Urol. 2015 May;67(5):943-51. doi: 10.1016/j.eururo.2014.11.055. Epub 2015 Feb 13.
10
Differing risk of cancer death among patients with pathologic T3a renal cell carcinoma: identification of risk categories according to fat infiltration and renal vein thrombosis.不同病理 T3a 肾细胞癌患者的癌症死亡风险：根据脂肪浸润和肾静脉血栓形成确定风险类别。
Clin Genitourin Cancer. 2013 Dec;11(4):451-7. doi: 10.1016/j.clgc.2013.05.006. Epub 2013 Jun 28.